CEPI-U.S. for CEPI-U.S.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Foreign Relations FOR
Education and advocacy supporting the funding and mission of the Coalition for Epidemic Preparedness Innovations (CEPI), including development of vaccines and other countermeasures for emerging diseases to help prevent and respond to epidemics and pandemics and strengthen global health security. H.R.8771, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2025, Title III, provisions relating to global health programs and global health security S. 4797, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2025, Title III, provisions relating to global health programs and global health security.
Foreign entity interest: The Coalition for Epidemic Preparedness Innovations (CEPI) is based in Norway, and its mission is to promote the development and availability of vaccines and other countermeasures against emerging epidemic and pandemic diseases. Lobbying efforts by CEPI-U.S. will support that mission.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL SKALLMAN | — |
Budget/Appropriations BUD
Education and advocacy supporting the funding and mission of the Coalition for Epidemic Preparedness Innovations (CEPI), including development of vaccines and other countermeasures for emerging diseases to help prevent and respond to epidemics and pandemics and strengthen global health security. H.R.8771, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2025, Title III, provisions relating to global health programs and global health security. S. 4797, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2025, Title III, provisions relating to global health programs and global health security.
Foreign entity interest: The Coalition for Epidemic Preparedness Innovations (CEPI) is based in Norway, and its mission is to promote the development and availability of vaccines and other countermeasures against emerging epidemic and pandemic diseases. Lobbying efforts by CEPI-U.S. will support that mission.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL SKALLMAN | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS | Norway | Norway | 100.0% | $60,000 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.